{"id":"W4309487094","doi":"10.1016/s1474-4422(22)00446-x","title":"Ublituximab: a new anti-CD20 agent for multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ocrelizumab; Ofatumumab; Teriflunomide; Medicine; Multiple sclerosis; Web of science; Daclizumab; Rituximab; Dermatology; Internal medicine; Fingolimod; Monoclonal antibody; Immunology; Antibody; Lymphoma; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005908942,0.0001604741,0.0005436902,0.00009442259,0.0005220276,0.0000184223,0.00043412,0.00004076285,0.0003128043],"category_scores_gemma":[0.0007509582,0.000113825,0.0001572488,0.0002575261,0.000159401,0.0000301778,0.0006086961,0.0005531266,0.00003836739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003995353,"about_ca_system_score_gemma":0.0001100165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001815195,"about_ca_topic_score_gemma":0.0000527138,"domain_scores_codex":[0.9980665,0.0002578295,0.0002297056,0.0003924886,0.000363672,0.0006897514],"domain_scores_gemma":[0.9982895,0.0007928052,0.00008110169,0.0006637947,0.00006128521,0.0001114718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006117108,0.0005231218,0.0983861,0.0001329569,0.0003490288,0.00004975826,0.001148946,0.0005201516,0.07007491,0.0005167433,0.789115,0.03306616],"study_design_scores_gemma":[0.008359303,0.001293121,0.3340262,0.000006419925,0.00005464709,0.00005011879,0.00006591246,0.002734739,0.0007120493,0.0001633032,0.652411,0.0001231884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8458338,0.0006994883,0.0001708174,0.1501866,0.000552467,0.001554801,0.0001297715,0.0001671224,0.0007051414],"genre_scores_gemma":[0.9758465,0.0005214496,0.0003862906,0.02084163,0.001006567,0.0005712707,0.00003088003,0.0000388585,0.0007565879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2356401,"threshold_uncertainty_score":0.4641649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2183592580892287,"score_gpt":0.341899105275114,"score_spread":0.1235398471858852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}